CD274 and neoplasm: Platelets coated with anti-PD-L1 were engineered by Gu and his colleagues to reduce, after resection, tumor recurrence in triple-negative breast carcinoma and melanoma in a mouse model and demonstrated that they successfully inhibited tumor recurrence when compared to controls [92].